Literature DB >> 15457465

First report of systemic reactive (AA) amyloidosis in a patient with the hyperimmunoglobulinemia D with periodic fever syndrome.

Laura Obici1, Carlo Manno, Andrea Onetti Muda, Paolo Picco, Andrea D'Osualdo, Giovanni Palladini, Maria Antonietta Avanzini, Diletta Torres, Sabrina Marciano, Giampaolo Merlini.   

Abstract

Systemic reactive (AA) amyloidosis, leading to renal failure, is a severe complication of most hereditary periodic fever syndromes. The risk of developing this life-threatening condition varies widely among these disorders, being higher for patients affected by familial Mediterranean fever and tumor necrosis factor receptor-associated periodic syndrome. In spite of an acute-phase response during attacks, amyloidosis has never, to date, been described in patients affected with the hyperimmunoglobulinemia D with periodic fever syndrome (HIDS). This is the first report to describe the occurrence of renal AA amyloidosis causing severe nephrotic syndrome in a young Italian man affected with HIDS. The diagnosis of HIDS was established according to clinical, laboratory, and genetic criteria as required by the international Nijmegen HIDS registry. In this patient, 2 mutations in the mevalonate kinase gene were identified, one of which, the leucine-to-arginine substitution at codon 265, is novel.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15457465     DOI: 10.1002/art.20490

Source DB:  PubMed          Journal:  Arthritis Rheum        ISSN: 0004-3591


  13 in total

Review 1.  Systemic amyloidosis: a challenge for the rheumatologist.

Authors:  Federico Perfetto; Alberto Moggi-Pignone; Riccardo Livi; Alessio Tempestini; Franco Bergesio; Marco Matucci-Cerinic
Journal:  Nat Rev Rheumatol       Date:  2010-06-08       Impact factor: 20.543

Review 2.  Treatment of hyperimmunoglobulinemia D syndrome with biologics in children: review of the literature and Finnish experience.

Authors:  Svetlana Kostjukovits; Liisa Kalliokoski; Kaisu Antila; Matti Korppi
Journal:  Eur J Pediatr       Date:  2015-02-27       Impact factor: 3.183

3.  [Amyloid diagnostics in rheumatic diseases].

Authors:  C Röcken; J Ernst
Journal:  Pathologe       Date:  2006-11       Impact factor: 1.011

4.  A patient with hyper-IgD syndrome responding to anti-TNF treatment.

Authors:  Erkan Demirkaya; M Kazim Caglar; Hans R Waterham; Rezan Topaloglu; Seza Ozen
Journal:  Clin Rheumatol       Date:  2006-12-15       Impact factor: 2.980

5.  Comments on the letter of Galland et al. on "A rare cause of AA amyloidosis and end-stage kidney failure".

Authors:  Mehmet Taşdemir; Sezen Yılmaz; Zeliha Füsun Baba; Ilmay Bilge
Journal:  Pediatr Nephrol       Date:  2019-05-22       Impact factor: 3.714

Review 6.  Hyperimmunoglobulin D syndrome in childhood.

Authors:  Jeroen C H van der Hilst; Joost Frenkel
Journal:  Curr Rheumatol Rep       Date:  2010-04       Impact factor: 4.592

7.  Renal AA amyloidosis: survey of epidemiologic and laboratory data from one nephrology centre.

Authors:  Z Potysová; M Merta; V Tesar; E Jancová; E Honsová; R Rysavá
Journal:  Int Urol Nephrol       Date:  2009-01-31       Impact factor: 2.370

Review 8.  Monogenic autoinflammatory diseases: concept and clinical manifestations.

Authors:  Adriana Almeida de Jesus; Raphaela Goldbach-Mansky
Journal:  Clin Immunol       Date:  2013-04-09       Impact factor: 3.969

Review 9.  Hereditary auto-inflammatory disorders and biologics.

Authors:  Leigh D Church; Sarah M Churchman; Philip N Hawkins; Michael F McDermott
Journal:  Springer Semin Immunopathol       Date:  2006-05-04

Review 10.  The Central Role of Anti-IL-1 Blockade in the Treatment of Monogenic and Multi-Factorial Autoinflammatory Diseases.

Authors:  Silvia Federici; Alberto Martini; Marco Gattorno
Journal:  Front Immunol       Date:  2013-10-31       Impact factor: 7.561

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.